Healthcare
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
30 Dec 2006 | North America | Market Research
U.S. Physicians Practice Management Systems (PPMS) Markets - Scheduling; Reporting; Billing and Claims for Ambulatory Care Providers
This Research Service analyzes market trends in the United States physicians practice management systems market since 2002, forecasts future changes in market measurements through 2012, and discusses specific challenges facing industry participants and strategic recommendations targeted to overcome these challenges. The physicians practice manageme...
$4,950.00 -
This Research Service analyzes market trends in the United States hospital information systems market since 2002, forecasts future changes in market measurements through 2012, and discusses specific challenges facing industry participants and strategic recommendations targeted to overcome these challenges. The hospital information systems market wa...
$4,950.00 -
01 Feb 2007 | North America | Market Research
Opportunity and Trends in the U.S. Personal Health Records Markets
This Research Service analyzes market trends in the United States personal health records market, provides an overview of the technical issues, and discusses specific challenges facing industry participants and strategic recommendations targeted to overcome these challenges. Trends and outlook for the United States personal health records market a...
$4,950.00 -
06 Feb 2007 | North America | Market Research
U.S. Disease Management Market for Remote Patient Monitoring Services
This research service analyzes the U.S. disease management market for remote patient monitoring services. The services focuses on remote patient monitoring applications for disease management companies. It includes discussions of market revenue forecasts, unit installations, and pricing. There is also an analysis of the drivers and restraints, a...
$4,950.00 -
26 Feb 2007 | North America | Market Research
U.S. Opioid and Non-Opioid Pain Management Pharmaceuticals Markets
This research service covers the U.S. opioid and non-opioid pain management pharmaceuticals markets and includes the long acting opioids, non-selective and selective non-steroidal anti-inflammatory drugs (NSAIDs). The research service provides a market overview, competitive structure, market forecasts and market share analysis across these two segm...
$4,950.00 -
The U.S. Multiple Myeloma Market is a rapidly progressing field that is set to generate over $3 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of three new drugs. The dynamics of this market are changing rapidly and the forecast through 2013 highlights the major changes. This study includes ...
$4,950.00 -
This research service analyzes the market for diabetes in vitro diagnostics within the United States. This service covers market trends, technology trends, competitive structure, revenue forecasts, market drivers and restraints. The key challenges and strategies are also covered.
$4,950.00 -
This research service provides an outlook of the U.S. generic pharmaceuticals market and includes the unbranded generic drugs sold within the U.S. The research service provides a market overview, trends, competitive landscape, market forecasts, market share analysis, industry challenges and opportunities.
$4,950.00 -
This research service covers the spinal surgery market in the United States. The market has been analyzed based on spinal implants such as fusion and fixation devices, artificial discs, vertebroplasty and prosthetic disc nuclei. Further, market dynamics and revenue forecast and analysis, and competitive landscape have been discussed for each of t...
$4,950.00 -
The U.S. Alzheimer's disease medication markets research service provides revenue and patient forecasts, competitive analysis, market trends, product analysis and strategies for growth. The market is segmented by product type into cholinesterase inhibitors, NMDA receptor antagonists and new mechanism drugs. Each of the segments discusses in detail ...
$4,950.00
